Menopausal hormone therapy: oncological risks
The review article presents an analysis of the literature over the past 10 years on the relationship of menopausal hormone therapy and the risks of developing malignant diseases in women, including risk factors, such as mutations in the BRCA1/2 genes. The main limiting factor in the appointment of m...
Saved in:
Main Authors: | Ekaterina V. Musina (Author), Igor Yu. Kogan (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Menopausal metabolic syndrome and the risks of menopausal hormone therapy: the solutions
by: A.E. Esedova, et al.
Published: (2020) -
Endometriosis, hormonal therapy and oncological risks
by: A.M. Grigorenko
Published: (2021) -
Menopausal hormonal therapy or non-hormonal treatment: rational choice
by: T Yu Pestrikova, et al.
Published: (2015) -
Menopausal hormone therapy and risk factors of breast cancer development
by: A E Protasova, et al.
Published: (2017) -
The choice of hormonal and alternative therapy in menopausal and post-menopausal period
by: Kuznetsova I.V
Published: (2018)